AHA disputes POLITICO story on hospitals decreasing community spending post-ACA

A POLITICO analysis said while the nation’s top hospitals saw a big jump in revenue after the Affordable Care Act took effect, they spent less on the charity care and community benefit spending often used to justify their tax-exempt status.

In one example, POLITICO said Massachusetts General Hospital—ranked best hospital by U.S. News and World Report in 2015—reported a $200 million increase in annual revenue between 2013 and 2015. Its community benefit spending, however, dropped from $62.1 million to $53.8 million over the same time frame.

“A lot of the communities where these hospitals are located are having financial difficulties,” said John Hopkins University health economist Gerard Anderson “The hospitals, which are making money, aren’t contributing to the financial reserves of that community. They are obviously employing people, but they are earning substantial profits and not paying any of those profits to the communities.”

American Hospital Association (AHA) President and CEO Rick Pollack called the story “inaccurate and incomplete,” claiming it doesn’t account for all the programs and services hospitals provide to communities, which he said goes above the value of the tax exemption.

“One out of every four hospitals in America operates in the red,” Pollack wrote on the AHA Stat blog. “Since 2010, hospitals have absorbed numerous payment reductions for services, estimated as high as $148.75 billion. The fact that the (Congressional Budget Office) estimates that between 40-50 percent of hospitals could have negative overall margins by 2025 underscores our belief that this piece fails to understand the financial pressures affecting hospital.”

Read the full POLITICO investigation at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.